No products
View larger | Quantity (mg or Unit) | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|
| 5 | $8.50 | Total: $42.50 |
| 10 | $7.20 | Total: $72.00 |
| 25 | $6.10 | Total: $152.50 |
| 50 | $5.20 | Total: $260.00 |
| 100 | $4.50 | Total: $450.00 |
| Molecular Formula | C12H21N5O3 |
| Molecular Weight | 283.33 |
| CAS Numbers | 64241-34-5 |
| Storage Condition | 0°C (short term), -20°C (long term), desiccated |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| Synonym | Cadralazine; ISF-2469; ISF 2469; ISF2469 |
| IUPAC/Chemical Name | Ethyl N-[[6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl]amino]carbamate |
| InChl Key | QLTVVOATEHFXLT-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) |
| SMILES Code | O=C(OCC)NNC1=NN=C(N(CC)CC(O)C)C=C1 |
| References | 1) Ebihara A, Fujimura A. Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet. 1991 Nov;21(5):331-43. Review. PubMed PMID: 1773548. 2) McTavish D, Young RA, Clissold SP. Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs. 1990 Oct;40(4):543-60. Review. PubMed PMID: 2083513. |